A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Condition(s):Ischemic Stroke; Ischemic Attack, TransientLast Updated:March 27, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Ischemic Stroke; Ischemic Attack, TransientLast Updated:March 27, 2024Recruiting
Condition(s):L L IschemiaLast Updated:October 10, 2023Not yet recruiting
Condition(s):Anterior Segment Ischemia (Diagnosis)Last Updated:February 3, 2021Completed
Condition(s):Coronary Artery DiseaseLast Updated:April 9, 2014Completed
Condition(s):Chronic Mesenteric IschemiaLast Updated:September 5, 2023Completed
Condition(s):Ischemia-Reperfusion InjuryLast Updated:March 28, 2008Suspended
Condition(s):Critical Limb Ischemia (CLI)Last Updated:January 8, 2019Available
Condition(s):Vascular Surgery; Ischemia-reperfusion; Ischemia PreconditioningLast Updated:April 27, 2022Terminated
Condition(s):Stroke, Acute; Ischemic StrokeLast Updated:October 25, 2023Terminated
Condition(s):Moyamoya Disease; Remote Ischemic PreconditioningLast Updated:September 19, 2019Suspended
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.